Title: IMen-Internal Medicine- Prevention of Type 2 Diabetes/Treatment of Obesity; Treatment of Hyperglycemia in Type 2 Diabetes (Non-Insulin); Treatment of Hyperglycemia in Type 2 Diabetes (Insulin)

Faculty: Merri Lou Pendergrass, M.D., Ph.D.

Original Release Date: July 1, 2021  Expiration Date: July 1, 2024

TOPIC 1: Prevention of Type 2 Diabetes/Treatment of Obesity.

Upon completion of this session, the participant should be able to: ^{GL, COMP}

1. Recognize patients with pre-diabetes.
2. Employ current Guidelines and recommendations regarding diabetes prevention.
3. Describe properties of currently available medications for obesity, their adverse effect profile, and how to incorporate them as part of an effective obesity treatment program.

TOPIC 2: Treatment of Hyperglycemia in Type 2 Diabetes (Non-Insulin)

Upon completion of this session, the participant should be able to: ^{EBM, GL, COMP}

1. Understand the glucose targets in T2DM.
2. Employ the current ADA Guidelines for pharmacological therapy.
3. Develop individualized therapeutic regimens to optimize glycemic control.

TOPIC 3: Treatment of Hyperglycemia in Type 2 Diabetes (Insulin)

Upon completion of this session, the participant should be able to: ^{EBM, GL, COMP}

1. Recognize indications for the initiation of insulin replacement therapy for people with T2DM.
2. Describe clinically relevant properties of the available insulins and insulin combinations.
3. Individualize and advance insulin therapy to optimize glycemic control.

Title: IMla-Internal Medicine- Lab Medicine : Anemia; Demystifying Transfusion; Arterial Blood Gas: A Six Step Approach to Rapid Interpretation

Faculty: Kevin Ferentz M.D. , Sarah Dubbs M.D., F.A.A.E.M., F.A.C.E.P. Arshad Wani M.D.

Original Release Date: July 1, 2021  Expiration Date: July 1, 2024

TOPIC 1: Anemia.

Upon completion of this session, the participant should be able to: ^{GL, COMP}

1. Develop a diagnostic strategy to ascertain the etiology of the anemia.
2. Utilize the guidelines for diagnosing anemia in children and adults in terms of available testing.
3. Develop a clinical approach to treating various anemias to include Iron Deficiency and “Anemia of Chronic Disease” due to infections, inflammatory dz’s, CKD, Malignancies, Cytokines, Interferons, TNF’s, etc.
4. Describe the role of consultants in the evaluation and management of anemia.

TOPIC 2: Demystifying Transfusion. 

Upon completion of this session, the participant should be able to: ^COMP

1. Identify and anticipate which patients are at risk for transfusion complications.
2. Recognize and manage transfusion complications.
3. Outline options and indications for special blood products to be used for transfusion.

TOPIC 3: Arterial Blood Gas: A Six Step Approach to Rapid Interpretation.

Upon completion of this session, the participant should be able to: ^COMP

1. Distinguish and determine the type of acid base disturbance – Acidosis and Alkalosis.
2. Determine the anion gap and its role in defining and treating acid base disorders.
3. Assess osmolal gap and urine anion gap.
4. Develop the management of acid base disorders by a case based discussion.

Title: IMpu-Internal Medicine- Pulmonary- Pneumonia; Pleural Diseases: Effusions and Pneumothorax; Non-Invasive Ventilation and Oxygenation in Respiratory Failure.

Faculty: Ganesan Murali, M.D. Arshad A. Wani, M.D.

Original Release Date: July 1, 2021  Expiration Date: July 1, 2024

TOPIC 1: Pneumonia.

Upon completion of this session, the participant should be able to: ^{EBM, COMP}

1. Differentiate the presentation of various cases of pneumonia and management.
2. Distinguish the different pathogens that cause pneumonia.
3. Apply evidence-based recommendations for prevention of pneumococcal pneumonia.
4. Plan the approach to health care associated pneumonia.

TOPIC 2: Pleural Diseases: Effusions and Pneumothorax.

Upon completion of this session, the participant should be able to: ^{GL, COMP}

1. Determine the etiology of various pleural effusions by means of cases.
2. Formulate the investigation and management of pleural effusions.
3. Detect the presentation of pneumothorax.
4. Develop the clinical approach to management of pneumothorax using the ACCP Delphi Guidelines.

TOPIC 3: Non-Invasive Ventilation and Oxygenation in Respiratory Failure.

Upon completion of this session, the participant should be able to: ^{GL, COMP}

1. Review the indications for NIV in acute respiratory failure.
2. Understand the benefits and risks of NIV.
3. Discuss the strategies for initiation of NIV and monitoring response.
4. Discuss the use of NIV on the wards, outside of the ICU setting.
5. Briefly review NIV use in COVID-19 patients.

Title: IMrd-Internal Medicine- Radiology : Incidentalomas: Dealing With Unexpected Abnormal Findings on Radiologic Exams; Contrast and Radiation Issues in Radiology: What a Clinician Should Know; Ultrasound Basics

Faculty: Adam R. Guttentag, M.D. Ryan K. Lee, M.D., M.B.A.

Original Release Date: July 1, 2021  Expiration Date: July 1, 2024

TOPIC 1: Incidentalomas: Dealing With Unexpected Abnormal Findings on Radiologic Exams.

Upon completion of this session, the participant should be able to: ^{EBM, COMP}

1. Apply an evidence-based approach to determine the need for further evaluation of abnormalities found incidentally on imaging tests.
2. Distinguish cystic renal masses that need imaging follow up from those that do not.
3. Select appropriate further imaging when needed for small adrenal masses.

TOPIC 2: Contrast and Radiation Issues in Radiology: What a Clinician Should Know.

Upon completion of this session, the participant should be able to: ^{EBM, GL, COMP}

1. Utilize evidence based guidelines to appropriately order intravenous contrast for CT scans for patients with impaired renal function.
2. Apply evidence based guidelines to decide whether it is safe to order intravenous contrast for MRI examinations.
3. Describe factors leading to increased radiation exposure to patients from medical imaging.
4. Select appropriate tests to order so as to minimize patient radiation dose without sacrificing diagnostic accuracy.

TOPIC 3: Ultrasound Basics.

Upon completion of this session, the participant should be able to: ^{COMP  EBM GL}

1. Discuss commonly used terms in ultrasound.
2. Determine in which clinical settings, based on the SRU Consensus Statement, ultrasound is the most appropriate study to order.
3. Recognize US findings for common diseases/diagnoses.

Title: IMrh-Internal Medicine- Rheumatology- Osteoporosis; Scleroderma and Raynaud's Disease; Rheumatoid Arthritis.

Faculty: Linda Brecher D.O., F.A.C.O.I., F.A.C.R., Lawrence Brent M.D.

Original Release Date: July 1, 2021  Expiration Date: July 1, 2024

TOPIC 1: Osteoporosis.

Upon completion of this session, the participant should be able to: ^{GL, EBM, COMP}

1. Detect patients who are at risk for osteoporosis.
2. Recognize the need for bone density testing as recommended by the International Society of Clinical Densitomethy and the National Osteoporosis Foundation guidelines.
3. Differentiate the nonpharmacologic and pharmacologic treatments for osteoporosis as recommended by the National Osteoporosis Foundation guidelines.

TOPIC 2: Scleroderma and Raynaud's Disease.

Upon completion of this session, the participant should be able to: ^{GL, COMP}

1. Specify the clinical manifestations of scleroderma.
2. Apply the ACR/EULAR classification criteria for systemic sclerosis.
3. Utilize treatment available for symptomatic manifestations as per the current EULAR recommendations.
4. Apply the diagnostic work-up and treatment of Raynaud’s Phenomenon.

TOPIC 3: Rheumatoid Arthritis.

Upon completion of this session, the participant should be able to: ^{GL, COMP}

1. Demonstrate the role of genetics, environmental factors, immune cells, and proinflammatory cytokines in the pathogenesis of rheumatoid arthritis.
2. Illustrate the clinical features, extra-articular manifestations, and complications of rheumatoid arthritis.
3. Utilize and compare various methods of measuring disease activity in rheumatoid arthritis.
4. Compare and contrast the mechanisms of action of current and emerging therapies for RA and prescribe treatment for patients with rheumatoid arthritis according to ACR guidelines.